Filippo Acconcia

Filippo Acconcia

Sep 24, 2017

Group 6 Copy 214
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

What can we do to improve survival in babies with respiratory distress in Bangladesh?

Respiratory Distress is a treatable disease which kills hundreds of thousands of babies every year. Most of...

Does Zika virus replicate in neural cells?

Zika virus is a rapidly emerging virus that is spreading throughout the Western Hemisphere. It is predicted...

Campaign Ended